Association of eicosapentaenoic acid (EPA) to arachidonic acid (AA) ratio with second trimester miscarriage

被引:0
|
作者
Mimura, N. [1 ]
Nagamatsu, T. [1 ]
Shitara, R. [1 ]
Furuya, H. [1 ]
Hara, A. [2 ]
Seyama, T. [1 ]
Nakayama, T. [1 ]
Iriyama, T. [1 ]
Osuga, Y. [1 ]
Fujii, T. [1 ]
机构
[1] Univ Tokyo Hosp, Dept Obstet & Gynecol, Tokyo, Japan
[2] Saitama Canc Ctr, Dept Gynecol, Saitama, Japan
关键词
D O I
10.1016/j.jri.2018.05.027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
OP6
引用
收藏
页码:51 / 51
页数:1
相关论文
共 50 条
  • [31] The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease
    Nelson, J. R.
    Raskin, S.
    POSTGRADUATE MEDICINE, 2019, 131 (04) : 268 - 277
  • [32] IMPACT OF RATIO OF EICOSAPENTAENOIC ACID TO ARACHIDONIC ACID ON CORONARY VASOMOTION IN RESPONSE TO ACETYLCHOLINE
    Chen, Po-Min
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1492 - E1492
  • [33] Eicosapentaenoic acid/arachidonic acid ratio in Japanese junior high school students
    Takahashi, Hiroshi
    Sano, Hironari
    Hayashi, Yuusaku
    Nishimura, Rimei
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [34] Eicosapentaenoic Acid/Arachidonic Acid Ratio in Japanese Type 2 Diabetic Patients
    Matsuzawa, Yoko
    Saito, Jun
    Omura, Masao
    Nishikawa, Tetsuo
    DIABETES, 2012, 61 : A555 - A555
  • [36] Clinical relevance of decreased ratios of serum eicosapentaenoic acid/arachidonic acid (AA) and docosahexaenoic acid/AA to impaired arterial stiffness
    Yoshida, Hiroshi
    Ito, Kumie
    Sato, Ryo
    Kurosawa, Hideo
    Tomono, Yoshiharu
    Hirowatari, Yuji
    Shimizu, Mitsuyuki
    Tada, Norio
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (02) : 517 - 519
  • [37] Effect of omega-3 fatty acid supplementation on the arachidonic acid: Eicosapentaenoic acid ratio
    Burns, Tammy
    Madejewski, Stephanie R.
    Hamilton, William R.
    Zheng, Margaret
    Mooss, Aryan N.
    Hilleman, Daniel E.
    PHARMACOTHERAPY, 2007, 27 (05): : 633 - 638
  • [38] The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy
    Tani, Shigemasa
    Nagao, Ken
    Kawauchi, Kenji
    Yagi, Tsukasa
    Atsumi, Wataru
    Matsuo, Rei
    Hirayama, Atsushi
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2017, 17 (05) : 409 - 420
  • [39] The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy
    Shigemasa Tani
    Ken Nagao
    Kenji Kawauchi
    Tsukasa Yagi
    Wataru Atsumi
    Rei Matsuo
    Atsushi Hirayama
    American Journal of Cardiovascular Drugs, 2017, 17 : 409 - 420
  • [40] The ratio of eicosapentaenoic acid (EPA) to arachidonic acid may be a residual risk marker in stable coronary artery disease patients receiving treatment with statin following EPA therapy
    Tani, S.
    Hirayama, A.
    Yagi, T.
    Atsumi, W.
    Ashida, T.
    Nagao, K.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1169 - 1170